Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
67 hedge funds and large institutions have $689M invested in Repare Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 10 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
5.69% more ownership
Funds ownership: 72.63% → 78.31% (+5.7%)
2% more funds holding
Funds holding: 66 → 67 (+1)
3% less capital invested
Capital invested by funds: $708M → $689M (-$18.2M)
7% less call options, than puts
Call options by funds: $207K | Put options by funds: $223K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$39.6M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$26.8M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$6.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$7.3M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$5.82M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$3.88M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.63M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.44M |
RPTX Hedge Fund Activity: Q4 2021 in Review
67 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2021, worth a combined $689M — down 2.6% from $708M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RPTX positions and 10 closed out — a net gain of 1 holder — while 29 added to existing stakes and 16 trimmed.
The largest buyer was Logos Global Management, adding an estimated $39.6M. The largest seller was Sectoral Asset Management, cutting an estimated $7.3M.
- 67 institutional investors held Repare Therapeutics (RPTX) as of Q4 2021, up from 66 in Q3 2021.
- Funds reported $689M of Repare Therapeutics stock for Q4 2021, down 2.6% quarter-over-quarter.
- 11 funds opened new Repare Therapeutics positions in Q4 2021 and 10 closed out, a net change of +1 holder.
- The largest Repare Therapeutics buyer in Q4 2021 was Logos Global Management, an estimated $39.6M added.
- The largest Repare Therapeutics seller in Q4 2021 was Sectoral Asset Management, an estimated $7.3M sold.
Based on aggregated 13F filings for Q4 2021.